Latest News

August 27, 2019

Pionyr Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages Read more

July 10, 2018

Pionyr Immunotherapeutics and ProBioGen Initiate a Second Immuno-Oncology Contract Development and Manufacturing Project View press release

December 13, 2017

Pionyr Immunotherapeutics Completes $62 million Series B Financing to Advance Antibody-Based Therapeutics Targeting the Tumor Microenvironment Read more

November 6, 2017

Pionyr Immunotherapeutics Appears in BioCentury View article

January 4, 2017

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics Read more

Past Events

November 12 - 13, 2019

Oncology Investor Conference, New York, NY
Pionyr Presentation

November 6 - 10, 2019

SITC 2019, National Harbor, MD
PY314 poster   PY159 poster

October 22 - 24, 2019

Macrophage-Directed Therapies Summit, Boston, MA

October 26 - 30, 2019

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium, Boston, MA
PY314 poster   PY159 poster

September 25 - 28, 2019

CICON 2019, Paris, France

September 27 - October 1, 2019

European Society for Medical Oncology, Barcelona, Spain

April 18, 2019

San Francisco Cancer Summit, One Tower Place, South San Francisco, CA

April 12, 2019

Future Leaders in Biotechnology Industry, Millennium Broadway Hotel, New York, NY

March 11 - 13, 2019

Cowen 39th Annual Health Care Conference, Boston Marriott Copley Place, Boston, MA
Pionyr Presentation (15MB)